ArticlePharmacology research & perspectives2025

Remifentanil Ameliorates Lipopolysaccharide-Induced Neuroinflammation by Regulating the Phosphatidylinositol 3-Kinase/Serine-Threonine Protein Kinase/Hypoxia-Inducible Factor 1 Alpha Pathway.

Mustafa Soner Özcan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.